Gauss Surgical, a Los Altos, CA-based provider of a mobile platform to monitor surgical blood loss, completed a $12M Series A financing round.
The round was led by Promus Ventures with participation from Summation Health Ventures and LifeForce Ventures. In conjunction with the funding, Mike Collett, General Partner at Promus Ventures, will be joining Gauss Surgical’s Board as an observer.
The company intends to use the funds to accelerate commercial growth of of its mobile platform.
Led by Milton B. McColl, M.D., Chief Executive Officer, and Siddarth Satish, Chairman, Founder, and Chief Technology Officer, Gauss Surgical provides the Triton System™, a mobile platform for real-time monitoring of surgical blood loss.
The company’s solution leverages mobile technology in combination with cloud computing. Using the iPad’s camera, the system scans surgical sponges and canisters, and sends the images to the cloud where algorithms estimate surgical blood loss in real-time. Triton, which is both FDA-cleared and HIPAA compliant, features an iPad interface and integrates into surgical workflow.
The technology is being implemented at Cedars-Sinai Medical Center, UC Irvine Healthcare, the Memorial Care Health System, and other leading health systems across the United States.
As part of Gauss Surgical’s commercialization strategy, the company has hired J. Scott Ashworth as Vice President of Sales. Ashworth brings more than 25 years of experience in building and leading global sales and marketing teams focused on commercialization of products and establishing distribution partnerships. Prior to joining Gauss Surgical, he served in executive sales roles at three medical device start-ups including Avinger and Heartflow. Previously, Ashworth was Vice President of Worldwide Sales and Service at Siemens Healthcare and held various leadership roles at Hewlett Packard Medical in sales and business development functions across the United States and Asia Pacific.
In his new role, he will focus on driving customer acquisition.